Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Lopinavir

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 447Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mylan's Generic Lopinavir and Ritonavir Receives Approval in the U.S.
    Mylan's Generic Lopinavir and Ritonavir Receives Approval in the U.S.

    07 Feb 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=079074

    FDA
    07 Feb 2024
    Share Share
    Cipla, DNDi launch 4-in-1 antiretroviral treatment for young children with HIV
    Cipla, DNDi launch 4-in-1 antiretroviral treatment for young children with HIV

    14 Jun 2022

    // EXPRESS PHARMA

    https://www.expresspharma.in/cipla-dndi-launch-4-in-1-antiretroviral-treatment-for-young-children-with-hiv-in-south-africa/

    EXPRESS PHARMA
    14 Jun 2022
    Share Share
    Laurus' Generic Lopinavir & Ritonavir Receives Approval in the U.S.
    Laurus' Generic Lopinavir & Ritonavir Receives Approval in the U.S.

    21 Mar 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213857

    FDA
    21 Mar 2022
    Share Share
    A giant trial of COVID-19 treatments is restarting
    A giant trial of COVID-19 treatments is restarting

    06 Aug 2021

    // Kai Kupferschmidt SCIENCEMAG

    https://www.sciencemag.org/news/2021/08/giant-trial-covid-19-treatments-restarting-here-are-drugs-it-s-betting

    Kai Kupferschmidt SCIENCEMAG
    06 Aug 2021
    Share Share
    Hetero Labs Ltd Iii's Generic Lopinavir; Ritonavir Receives Approval In US
    Hetero Labs Ltd Iii's Generic Lopinavir; Ritonavir Receives Approval In US

    04 Jun 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091677

    FDA
    04 Jun 2021
    Share Share
    Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
    Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

    03 Dec 2020

    // NEJM

    https://www.nejm.org/doi/full/10.1056/NEJMoa2023184?rss=searchAndBrowse

    NEJM
    03 Dec 2020
    Share Share